<DOC>
	<DOCNO>NCT01007214</DOCNO>
	<brief_summary>Evaluate accuracy HIT guide biopsy map tumor foci men undergo prostatectomy .</brief_summary>
	<brief_title>Guided Biopsy Mapping Prostate Cancer</brief_title>
	<detailed_description>The objective study determine accuracy HIT ( Hybrid Imaging Technology ) guide biopsy map tumor foci men undergo prostatectomy . Using prostate hybrid image technology ( HIT ) fuse previously obtain endorectal MR image transrectal ultrasound ( TRUS ) image allow identification biopsy tumor MR image real time . We hypothesis HIT guide biopsy accurately localize foci prostate cancer .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Patients must histologically confirm diagnosis prostate cancer Patients must elect undergo radical prostatectomy use open , laparoscopic robotic approach Patients must least 18 year age able provide write informed consent . No history radiotherapy , chemotherapy hormone therapy within 6 month surgery Primary tumor must amenable surgical removal curative intent Patients must ECOGperformance status 0 1 ( appendix II ) Patients must history rectal anal disease . Patients must adequate organ function define follow criterion : Serum aspartate transaminase ( AST ; serum glutamic oxaloacetic transaminase [ SGOT ] ) serum alanine transaminase ( ALT ; serum glutamic pyruvic transaminase [ SGPT ] ) ≤2.5x local laboratory upper limit normal ( ULN ) , AST ALT ≤5x ULN liver function abnormality due underlie malignancy Total serum bilirubin ≤1.5 x ULN Absolute neutrophil count ( ANC ) ≥1,500/microL Platelets≥lOO , OOO/microL Hemoglobin≥9.0 g/dL Serum calcium≤10.2mg/dL ( correct low albumin necessary ; calcium + ( normal albumin serum albumin ) x 0.8 ) Patients must serum creatinine &lt; 2 mg/dL serum creatinine clearance ( CrCl ) &gt; 40ml/min ( CrCl= Wt ( kg ) x ( 140age ) */72xCr . level , *female x 0.85 ) Inclusion minority : Members race ethnic group eligible trial . Women child eligible since prostate cancer diagnose group .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>Prostatectomy</keyword>
</DOC>